Mastodon Feed
Boosted by jsonstein@masto.deoan.org ("Jeff Sonstein"):
flexghost ("flexghost.") wrote:
Amazing.
A personalized mRNA cancer vaccine just succeeded in a 1,137-patient Phase 3 melanoma trial…
Each vaccine is built from mutations in that individual patient’s tumor
Earlier results have now held for 5 years: 49% lower risk of recurrence or death / 59% lower risk of distant metastasis or death
Waiting on full Phase 3 data but something that seemed like a far off dream could be a reality!
